EDITORIAL SECTION

Articles

Strategic Partnerships and Collaborations in the European Pharmaceutical Industry

Pharma strategic partnerships are formal agreements in which two or more companies share resources risk and rewards to develop or commercialize medicines In Europe the main models are licensing codevelopment cocommercialization joint ventures and publicprivate consortia Companies choose based on how much risk they want to share how much control they need to keep

Access to Affordable Medicines: A Persistent Challenge for Europe

The problem of affordable medicines has been topical in Europe for many years Despite the fact that there are well developed health units in many regions of the world and particularly in this continent the health challenges of the population have not been fully met especially in access to affordable basic medicines This problem is relevant not only to the patients but also to the stability of heal...

Why AI Is Changing What Good Validation Looks Like

The comprehensive landmark report and framework set out seven principles for using AI safely in pharmacovigilance together advocating a riskbased approach to governance validation and more Here ArisGlobals Jason Bryant highlights some of the guidances main assumptions as recently distilled in a podcast with Denny Lorenz a core member of the CIOMS XIV working group

Top 5 Pharma Content Formats That Drive Engagement and Leads

The pharmaceutical business is experiencing a significant change in the way it informs the healthcare professionals decisionmakers and business partners Conventional means of promotion is no longer sufficient in a context whereby buyers do a lot of research before involving themselves with vendors Consequently pharma content marketing has turned out to be a vital instrument of establishing credibi...

Genomics and Precision Medicine: Exploring the Role of Genomics in Identifying Genetic Markers for Disease Susceptibility and Treatment Response

The advent of genomics has ushered in a new era of healthcare characterized by a paradigm shift from onesizefitsall medicine to precision medicine This transformative approach leverages the power of genetic information to tailor medical interventions to individual patients optimizing treatment efficacy and minimizing adverse effects

Digital Twins: The Future Blueprint for Pharmaceutical Production

Digital Twins have revolutionized the pharmaceutical industry by providing virtual replicas of physical assets and processes This innovative technology offers a comprehensive view of manufacturing

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys